EGM
ZBIO

Engineers Gate Manager’s Zenas BioPharma ZBIO Stock Holding History

Engineers Gate Manager’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
+12,980
New +$258K ﹤0.01% 1729

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Engineers Gate Manager's ZBIO Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Zenas BioPharma (ZBIO) in Q2 2026: 12,980 shares worth $329K. The stake represents ﹤0.01% of the portfolio and ranks #1729 among its holdings.

145 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Engineers Gate Manager held 12,980 shares of Zenas BioPharma worth $329K as of Q2 2026.
  • Zenas BioPharma was a new Engineers Gate Manager position in Q2 2026.
  • Zenas BioPharma made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1729 holding.
  • 145 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.